<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04543656</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT04543656</nct_id>
  </id_info>
  <brief_title>Personalized Blood Pressure Care Using IoMTs and Artificial Intelligence</brief_title>
  <official_title>Personalized Blood Pressure Care for Prehypertensive Patients Using IoMTs and Artificial Intelligence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this RCT, up to 100 adults classified as pre-hypertensive will be randomized to either an&#xD;
      artificial intelligence (AI) based lifestyle intervention group or an active control group&#xD;
      with a 1 to 1 ratio. Both groups will receive an identical activity tracker (Samsung Galaxy&#xD;
      Watch) and BP monitor (Omron Evolv). The AI intervention group will receive automated and&#xD;
      personalized lifestyle recommendations based on their lifestyle (e.g. sleep, exercise and&#xD;
      diet) and blood pressure (BP) data, involving an automated analytics engine using statistics&#xD;
      and machine learning. The active control group will not receive these lifestyle&#xD;
      recommendations. The investigators aim to assess objectively the effectiveness of the&#xD;
      AI-based personalized lifestyle recommendations on the patients BP.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average change in systolic blood pressure (SBP) in experimental vs. control group</measure>
    <time_frame>Initial 2 week data collection, weekly lifestyle recommendations, 6 months total</time_frame>
    <description>Average SBP during the first and last week of a patient's enrollment will be used to calculate SBP change for each patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Average change in diastolic blood pressure (DBP) in experimental vs. control group</measure>
    <time_frame>Initial 2 week data collection, weekly lifestyle recommendations, 6 months total</time_frame>
    <description>Average DBP during the first and last week of a patient's enrollment will be used to calculate DBP change for each patient.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients in experimental group that followed lifestyle recommendations</measure>
    <time_frame>Initial 2 week data collection, weekly lifestyle recommendations, 6 months total</time_frame>
    <description>This secondary outcome measure is interested in assessing patient engagement within the experimental group. Data from the activity tracker (steps, sleep quality, active minutes, etc.) will be used to assess whether a patient followed the lifestyle recommendations.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pre-hypertension</condition>
  <arm_group>
    <arm_group_label>AI-Based Lifestyle Recommendations Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group receive AI-based, personalized lifestyle recommendations based on analysis of their activity tracker and blood pressure data.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group do not receive the lifestyle recommendations, but are provided with an identical activity tracker and blood pressure monitor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>AI-Based Lifestyle Recommendations</intervention_name>
    <description>The intervention provides participants with automated and personalized lifestyle recommendations involving a sophisticated analytics engine using advanced statistics and machine learning.</description>
    <arm_group_label>AI-Based Lifestyle Recommendations Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Lifestyle Recommendations</intervention_name>
    <description>The control group receives an identical activity tracker and BP monitor in order to objectively assess the effectiveness of the experimental group intervention.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age â‰¥18 years&#xD;
&#xD;
          -  SBP between 130 mmHg to 139 mmHg or/and DBP between 80 to 89 mmHg in a research office&#xD;
&#xD;
          -  speaking and reading English&#xD;
&#xD;
          -  having an iPhone 8 or newer or an Android x or newer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  currently taking antihypertensive medication&#xD;
&#xD;
          -  self-reported diagnosis of coronary heart disease, medical condition or other physical&#xD;
             problem necessitating special attention in an exercise program (e.g., cancer, eating&#xD;
             disorder, uncontrolled diabetes)&#xD;
&#xD;
          -  current participation in a lifestyle modification program or research study&#xD;
&#xD;
          -  self-report of being currently pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sujit Dey, PhD</last_name>
    <phone>8587617518</phone>
    <email>dey@eng.ucsd.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sujit Dey</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://ieeexplore.ieee.org/abstract/document/8822927</url>
    <description>Offline and Online Learning Techniques for Personalized Blood Pressure Prediction and Health Behavior Recommendations</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 10, 2020</study_first_submitted>
  <study_first_submitted_qc>September 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2020</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Sujit Dey</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prehypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

